JMDC Inc
TSE:4483

Watchlist Manager
JMDC Inc Logo
JMDC Inc
TSE:4483
Watchlist
Price: 3 665 JPY -3.17%
Market Cap: 239.8B JPY

JMDC Inc's latest stock split occurred on Sep 29, 2020

The company executed a 2-for-1 stock split, meaning that for every share held, investors received 2 new shares.

Before the split, JMDC Inc traded at 8840 per share. Afterward, the share price was about 4563.0229.

The adjusted shares began trading on Sep 29, 2020. This was the only stock split in JMDC Inc's history.

Last Splits:
Sep 29, 2020
2-for-1
Pre-Split Price
4 413.2519 8 840
Post-Split Price
4 563.0229
Before
After
Last Splits:
Sep 29, 2020
2-for-1

JMDC Inc
Stock Splits History

JMDC Inc Stock Splits Timeline
Sep 29, 2020
Sep 29, 2020
Split 2-for-1
x2
Pre-Split Price
4 413.2519 8 840
Post-Split Price
4 563.0229
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Dec 29, 2025
Ise Chemicals Corp
OTC:ICHMF
10-for-1
x10
32.808 32.808 USD N/A
Dec 29, 2025
Bridgestone Corp
OTC:BRDCF
2-for-1
x2
45.78 45.78 USD N/A
Dec 29, 2025
Ibiden Co Ltd
OTC:IBIDF
2-for-1
x2
81 81 USD N/A
Dec 29, 2025
Itochu Corp
OTC:ITOCF
5-for-1
x5
62.79 62.79 USD N/A
Dec 29, 2025
Sumitomo Realty & Development Co Ltd
OTC:SURDF
2-for-1
x2
47.945 47.945 USD N/A
Load More

JMDC Inc
Glance View

Market Cap
239.7B JPY
Industry
Health Care

Amidst the complex intersection of healthcare and technology, JMDC Inc. has carved a unique niche by harnessing the power of big data to improve healthcare outcomes and efficiency. Founded in Japan, the company stands as a beacon in the health informatics sector, meticulously collecting and analyzing health-related data drawn from a variety of sources, including medical claims, health screenings, and electronic health records. By transforming this extensive data trove into actionable insights, JMDC offers healthcare providers, pharmaceutical companies, and insurance firms the analytics they need to make informed decisions. Key to JMDC's operation is its commitment to safeguarding patient anonymity while extracting valuable insights that can streamline healthcare delivery, enhance pharmaceutical research, and optimize insurance underwriting. JMDC's revenue model hinges on the sale of its aggregated data and analytics solutions to a vast array of stakeholders in the medical field. Pharmaceutical companies, eager to understand drug efficacy and patient demographics better, turn to JMDC for data-driven insights that can influence drug development and marketing strategies. Insurance companies leverage JMDC's data to refine their offerings and better assess risk, ensuring competitive pricing models and improved customer satisfaction. Moreover, healthcare providers utilize this analytics backbone to enhance operational efficiency and improve patient care outcomes. Through licensing agreements and subscription-based services, JMDC effectively monetizes its data resources, achieving sustained growth in an industry that increasingly values the marriage of technology and healthcare.

Intrinsic Value
4 115.31 JPY
Undervaluation 11%
Intrinsic Value
Price
Back to Top